Report Description

India oxytetracycline market is expected to grow at a steady rate during the forecast period. Rising number of infections amongst population is one of the key factor which is anticipated to drive the growth of India oxytetracycline market in near future. Additionally, due to better absorption profile, the drug is preferred for the treatment of moderately severe acne which is expected to boost the demand through FY2026. Improvement in healthcare infrastructure is further predicted to bolster the market growth in the years to come.

The India oxytetracycline market is segmented based on type, route of administration, source, form, distribution channel, application, company, and region. Based on form, the market is segmented into capsule, tablet, injection, syrup, eye drops. Among them, the tablet segment dominates the market until FY2020 and is estimated to maintain its leading position during then forecast years as well on account of their longer shelf life than other alternatives present in the market. Also, the capsule segment is anticipated to grow at a high CAGR in the years to come as they are fast-acting, powerful and get absorbed into the bloodstream readily.

The major players operating in the India oxytetracycline market are Alpa Laboratories Ltd., Jagsonpal Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd., Gracure Pharmaceuticals Ltd., Unicure India Pvt. Ltd., Pfizer Ltd. (Pharmacia India Pvt. Ltd.), Wockhardt Healthcare Ltd., Optho Remedies Pvt. Ltd., Cyper Drugs & Pharmaceuticals Pvt. Ltd., Bini Laboratories Pvt. Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies, and launching new products in order to stay competitive in the market. Other inorganic growth strategies include mergers & acquisitions, joint ventures, and new product developments in order to sustain themselves amidst fierce competition.

Years considered for this report:

Historical Years: FY2016-FY2019

Base Year: FY2020

Estimated Year: FY2021

Forecast Period: FY2022–FY2026

Objective of the Study:

  • To analyze and estimate the market size of India oxytetracycline market from FY2016 to FY2019.
  • To estimate and forecast the market size of India oxytetracycline market from FY2020 to FY2026 and growth rate until FY2026.
  • To classify and forecast India oxytetracycline market based on type, route of administration, source, form, distribution channel, application, company, and regional distribution.
  • To identify dominant region or segment in the India oxytetracycline market.
  • To identify drivers and challenges for India oxytetracycline market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India oxytetracycline market.
  • To identify and analyze the profile of leading players operating in India oxytetracycline market.
  • To identify key sustainable strategies adopted by market players in India oxytetracycline market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India oxytetracycline market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Oxytetracycline manufacturers/ suppliers/ distributors
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to oxytetracycline

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India oxytetracycline market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Oxytetracycline Market, By Type:
    • Pharmaceutical Grade
    • Veterinary Grade
  • India Oxytetracycline Market, By Route of Administration:
    • Oral
    • Intravenous
    • Topical
  • India Oxytetracycline Market, By Source:
    • In-house
    • Contract Manufacturing Organizations
  • India Oxytetracycline Market, By Form:
    • Tablet
    • Capsule
    • Injection
    • Ointment
    • Syrup
  • India Oxytetracycline Market, By Distribution Channel:
    • Online
    • Offline
  • India Oxytetracycline Market, By Application:
    • Urinary Tract Infection
    • Respiratory Infection
    • Skin
    • Eye and Ear Infections
    • Others
  • India Oxytetracycline Market, By Region:
    • North
    • South
    • East
    • West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India oxytetracycline market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India oxytetracycline market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Oxytetracycline Market

4.    Executive Summary

5.    Manufacturing Oxytetracycline

5.1.  Raw Material

5.2.  Machinery

5.3.  Manufacturing Methods

5.4.  Contact Details of Machinery & Raw Material Suppliers

6.    Pharmacodynamic Overview of Oxytetracycline

6.1.  Mechanism of Action

6.2.  Absorption

6.3.  Volume of Distribution

6.4.  Protein Binding

6.5.  Metabolism

6.6.  Route of Elimination

6.7.  Half-Life

6.8.  Clearance

6.9.  Toxicity

7.    India Oxytetracycline Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Type (Pharmaceutical grade, Veterinary grade)

7.2.2.     By Route of administration (Oral, Intravenous, Topical)

7.2.3.     By Source (In-house v/s Contract Manufacturing Organizations)

7.2.4.     By Form (Tablet, Capsule, Injection, Ointment, Syrup)

7.2.5.     By Distribution Channel (Online v/s Offline)

7.2.6.     By Application (Urinary Tract Infection, Respiratory Infection, Skin, Eye and Ear Infections and Others)

7.2.7.     By Region (North, East, South, West)

7.2.8.     By Company

7.3.  Product Market Map

8.    Market Dynamics

8.1.  Drivers/Opportunities

8.2.  Challenges/Restraints

9.    Market Trends & Developments

10.  Policy & Regulatory Landscape

10.1.              Custom Duty & Taxes

10.2.              Government Subsidy & Benefits

10.3.              Relevant Policies & Regulations (GMP, USFDA, WHO Certifications)

11.  Import & Export Analysis

12.  Pricing Analysis

13.  India Economic Profile

14.  Competitive Landscape

14.1.              Company Profiles

14.1.1.  Alpa Laboratories Ltd.      Company Brief      Production Plants & Capacity (If Available)      Financials (If Available)      Captive Consumption Vs Merchant Sale      Current & Future Plans

14.1.2.  Jagsonpal Pharmaceuticals Ltd.

14.1.3.  Cadila Pharmaceuticals Ltd.

14.1.4.  Gracure Pharmaceuticals Ltd.

14.1.5.  Unicure India Pvt. Ltd.

14.1.6.  Pfizer Ltd. (Pharmacia India Pvt. Ltd.)

14.1.7.  Wockhardt Healthcare Ltd.

14.1.8.  Optho Remedies Pvt. Ltd.

14.1.9.  Cyper Drugs & Pharmaceuticals Pvt. Ltd.

14.1.10. Bini Laboratories Pvt. Ltd.

15.  Strategic Recommendations

About Us & Disclaimer

Figures and Tables

Frequently asked questions